Article
CBP/p300 acetyltransferase activity in hematologic malignancies.
Molecular genetics and metabolism - 1 Sept 2016
Dutta Ritika, Tiu Bruce, Sakamoto Kathleen M
Abstract excerpt
CREB binding protein (CBP) and p300 are critical regulators of hematopoiesis through both their transcriptional coactivator and acetyltransferase activities. Loss or mutation of CBP/p300 results in hematologic deficiencies in proliferation and differentiation as well as disruption of hematopoietic stem cell renewal and the microenvironment. Aberrant lysine acetylation mediated by CBP/p300 has recently been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
